🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 4

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 4 of 11
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Feb 23, 2024 at 11:33 AM#16

From the other side of the consultation, briefly. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Ask again with the specifics and you will get a better answer than this one.

47 20FDA_TrackerJim, ricardo_MIA, BrianDallas92 and 44 others
Reply Quote Save Share Report
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Feb 26, 2024 at 12:04 AM#17
dave_SLC said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Adding the part of the answer the thread has not reached. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

48 21DadBodDave, AmyNC_wife, SkepticalSean and 45 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Feb 28, 2024 at 12:34 PM#18

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

49 22Dr.EndoIndy, tom_AK, josh_phd_bmore and 46 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Mar 2, 2024 at 1:02 AM#19

One thing that is still open after dave_SLC’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Mar 2, 2024 at 4:02 AM
50 23TirzTom, TrialTracker_MD, JennaRN and 47 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 4, 2024 at 1:29 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here. Tagging this one for the weekly digest.

Last edited: Mar 4, 2024 at 3:29 PM
22 20PurityPaulOR, MaxMetOK, MounjBrad and 19 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register